The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Takayama, Makoto ^a   Yao, Kozo ^a   Wada, Michihito ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMLODIPINE; BENIDIPINE; CALCIUM; FURA 2; LYSOPHOSPHATIDYLCHOLINE; NIFEDIPINE; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; BLEACHING; CALCIUM CELL LEVEL; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FLUORESCENCE; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; ANIMAL; AORTA; CHEMISTRY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; METABOLISM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

RATTUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; AORTA; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE; DIHYDROPYRIDINES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; LYSOPHOSPHATIDYLCHOLINES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 68249153968     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-57     Document Type: Article

References (28)

1. Lipids and the endothelium. AM Dart JP Chin-Dusting, Cardiovasc Res 1999 43 308 322 10536661 10.1016/S0008-6363(99)00150-9 (Pubitemid 29356369)
2. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. S Ylä-Herttuala W Palinski ME Rosenfeld S Parthasarathy TE Carew S Butler JL Witztum D Steinberg, J Clin Invest 1989 84 1086 1095 2794046 10.1172/JCI114271
3. 2+mobilization in intact endothelial cells of rabbit aorta. Y Miwa K Hirata S Kawashima H Akita M Yokoyama, Arterioscler Thromb Vasc Biol 1997 17 1561 1567 9301636
4. 2+] i signaling. TY Huang HI Chen CY Liu CJ Jen, J Biomed Sci 2002 9 327 333 12145530
5. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. K Kugiyama M Ohgushi S Sugiyama T Murohara K Fukunaga E Miyamoto H Yasue, Circ Res 1992 71 1422 1428 1423937
6. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells. NA Flavahan, Am J Physiol 1993 264 H722 H727 8456975
7. Effects of lysophosphatidylcholine on bovine aortic endothelial cell in culture. Z Su Q Ling ZG Guo, Cardioscience 1995 6 31 37 7605894
8. Perturbation by lysophosphatidylcholine of membrane permeability in cultured vascular smooth muscle and endothelial cells. YM Leung Y Xion YJ Ou CY Kwan, Life Sci 1998 63 965 973 9747897 10.1016/S0024-3205(98)00354-3 (Pubitemid 28392041)
9. Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker. K Yao K Nagashima H Miki, J Pharmacol Sci 2006 100 243 261 16565579 10.1254/jphs.DTJ05001X
10. Effects of combination of angiotensin receptor blocker and calcium channel blocker on ox-LDL levels and cardiovascular dysfunction in Dahl rats. M Takayama E Arakawa K Yao Y Ina H Sato K Hasegawa H Kohno T Ohno, Pharmacology 2006 77 179 187 16864986 10.1159/000094656 (Pubitemid 44335004)
11. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits. M Takayama M Matsubara E Arakawa C Takada Y Ina K Hasegawa K Yao, Vascul Pharmacol 2007 46 302 308 10.1016/j.vph.2006.11.004 17197250 (Pubitemid 46124094)
12. 2+channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells. M Matsubara K Hasegawa, Eur J Pharmacol 2004 498 303 314 15364009 10.1016/j.ejphar.2004.07.086 (Pubitemid 39208093)
13. Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. M Matsubara K Hasegawa, Atherosclerosis 2005 178 57 66 15585201 10.1016/j.atherosclerosis.2004.08.020 (Pubitemid 39600816)
14. Benidipine, a dihydropyridine-calcium channel blocker, inhibits lysophosphatidylcholine-induced endothelial injury via stimulation of nitric oxide release. M Matsubara K Yao K Hasegawa, Pharmacol Res 2006 53 35 43 16172001 10.1016/j.phrs.2005.08.006 (Pubitemid 41619377)
15. Ion channels and regulation of intracellular calcium in vascular endothelial cells. DJ Adams J Barakeh R Laskey C Van Breemen, FASEB J 1989 3 2389 2400 2477294
16. Renoprotective effects of benidipine in combination with angiotensin II type 1 receptor blocker in hypertensive Dahl rats. K Yao H Sato Y Ina K Suzuki T Ohno S Shirakura, Hypertens Res 2003 26 635 641 14567503 10.1291/hypres.26.635 (Pubitemid 37086636)
17. Antihypertensive effects of nifedipine on conscious normotensive and hypertensive rats. T Kubo K Fujie M Yamashita Y Misu, J Pharmacobiodyn 1981 4 294 300 7264875
18. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats. A Karasawa K Kubo K Shuto T Oka N Nakamizo, Arzneimittelforschung 1988 38 1684 1690 3064752 (Pubitemid 18275187)
19. Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent. N Yamamoto M Nomura K Okubo K Maeda T Goto, J Cardiovasc Pharmacol 1999 33 587 594 10218729 10.1097/00005344-199904000-00011 (Pubitemid 29164822)
20. Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. K Kugiyama S Sugiyama N Ogata H Oka H Doi Y Ota H Yasue, Atherosclerosis 1999 143 201 204 10208496 10.1016/S0021-9150(98)00288-3 (Pubitemid 29138719)
21. Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia: the possible role of peroxynitrite (ONOO(-)). T Hayashi K Yamada T Esaki H Kano Y Asai N Kumar Thakur M Jayachandran D Sumi A Iguchi, Atherosclerosis 1999 147 349 363 10559521 10.1016/S0021-9150(99)00205-1 (Pubitemid 29512267)
22. Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide. IT Mak J Zhang WB Weglicki, Pharmacol Res 2002 45 27 33 11820858 10.1006/phrs.2001.0903 (Pubitemid 35425508)
23. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. R Berkels G Egink TA Marsen H Bartels R Roesen W Klaus, Hypertension 2001 37 240 245 11230278
24. Antioxidant effects of calcium antagonists in rat brain homogenates. K Yao Y Ina K Nagashima K Ohmori T Ohno, Biol Pharm Bull 2000 23 766 769 10864033
25. The antioxidant butylated hydroxytoluene protects against atherosclerosis. I Björkhem A Henriksson-Freyschuss O Breuer U Diczfalusy L Berglund P Henriksson, Arterioscler Thromb 1991 11 15 22 1987993
26. Membrane function and vascular reactivity. RJ Bing A Termin A Conforto R Dudek MJ Hoffmann, Biosci Rep 1993 13 61 67 8397007 10.1007/BF01145958
27. Pharmacokinetic study of benidipine hydrochloride in rats and dogs. H Kobayashi S Kobayashi A Inoue T Oka N Nakamizo, Arzneimittelforschung 1988 38 1750 1753 3219154 (Pubitemid 18275201)
28. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. K Kugiyama SA Kerns JD Morrisett R Roberts PD Henry, Nature 1990 344 160 162 2106627 10.1038/344160a0 (Pubitemid 20094133)